Wynnewood based MLH Explorations, LLC, recently won approval to expand its medical marijuana growing facility in Falls Township, Bucks County.
According to the Bucks County Courier:
On Tuesday, supervisors voted 3-0 to grant MLH Exploration LLC’s proposal to construct a near 50,000-square-foot addition to its medical marijuana growing and processing facility at the former U.S. Steel property in Falls. After getting the green light from the state to supply cannabis, a company is set to expand its medical marijuana facility at the former U.S. Steel property in Falls.
The newly approved construction will be an addition to the company’s 32-acre growing and processing plant.
In July of 2019, the Inquirer reported that, “The first medical marijuana dispensary to be affiliated with a major Pennsylvania health system is slated to open this Fall in one of Philadelphia’s most historic neighborhoods. Solterra Care received zoning approval in late May for a 4,400 square foot facility at 809 Locust Street, a block west of Washington Square.
In late June, Solterra’s parent company, MLH Explorations LLC, won a highly-coveted permit to partner with the Sidney Kimmel Medical College at Thomas Jefferson University. The so-called Clinical Research permit — one of only three awarded by the state — also will allow MLH to grow and process marijuana on the site of a former U.S. Steel Plant in Fairless Hills, in Bucks County. “
When MLH Explorations filed its Clinical Registration application with the Pennsylvania Department of Health, the company gave 308 E. Lancaster Avenue in Wynnewood as its location. That is the same location as the headquarters of Main Line Investment Partners. The exact relationship between MLH and Main Line Investment Partners is not known. However, in addition to sharing the same location, two of the leading principals of Main Line Investment Partners (William Landman and David Clapper) are also listed officers of MLH’s wholly owned dispensary company, Solterra Care.
In March of 2018 the Inquirer reported that “Landman’s business partner, David Clapper, said many Jefferson doctors were strong supporters of medical marijuana before the law was passed. ‘One oncologist said 30 percent of his cancer patients were already using it’ to relieve acute pain and stimulate their appetites, Clapper said. MainLine is making “a sizable investment” to build the Solterra CR from scratch. The state requires a minimum commitment of $15 million, ‘but it’s going to cost a lot more than that,’ said Clapper.
On June 21 the Inquirer reported that “The Pennsylvania Department of Health on Thursday announced that it had approved three companies to grow medical marijuana for research in partnership with medical schools at Drexel, Thomas Jefferson, and Penn State in Hershey, Pa.” MLH in conjunction with Jefferson, was one of the three companies named. Landman is a member of the board and former Chairman of Thomas Jefferson University Health System.
A spokesperson for Landman said that he recused himself from decisions involving Jefferson and his medical cannabis company,